(Q45188894)

10 December 2017

title

Induction chemotherapy in head and neck cancer: results of a phase III trial (English)

1 reference

10 December 2017

main subject

phase III clinical trial

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

Mazeron JJ

1

1 reference

10 December 2017

Martin M

2

1 reference

10 December 2017

Brun B

3

1 reference

10 December 2017

Grimard L

4

1 reference

10 December 2017

Lelièvre G

5

1 reference

10 December 2017

Vergnes L

6

1 reference

10 December 2017

Haddad E

7

1 reference

10 December 2017

Feuilhade F

8

1 reference

10 December 2017

Piedbois P

9

1 reference

10 December 2017

Strunski W

10

1 reference

10 December 2017

language of work or name

1 reference

1 March 1992

1 reference

10 December 2017

1 reference

10 December 2017

volume

14

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

85-91

1 reference

Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

Prognostic factors for loco/regional control and metastasis and the impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Supraglottic laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

What's in a Name--Neoadjuvant

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

The case for a name change from neoadjuvant chemotherapy to induction chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120-hour infusion 5-fluorouracil in Stage III and IV squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin.

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

An intensive, five course, alternating combination chemotherapy induction regimen used in patients with advanced, unresectable head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

The effects of delay in standard treatment due to induction chemotherapy in two randomized prospective studies

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. A preliminary report

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Randomized study of adjuvant chemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Sequential chemotherapy and radiotherapy in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Combined modality treatment with radiotherapy and chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Adjuvant chemotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.2880140202

7 January 2021

Identifiers

DOI

10.1002/HED.2880140202

1 reference

10 December 2017

1 reference